New cancer drug enters human testing for Tough-to-Treat tumors
Disease control
Recruiting now
This is a first-in-human study to find a safe dose of a new drug called BAL0891. It will test the drug alone and in combination with other cancer therapies in 260 adults with advanced solid tumors or a type of leukemia that has returned or not responded to treatment. The main goa…
Phase: PHASE1 • Sponsor: SillaJen, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC